INHIBITION OF HIV-1 PROTEASE BY SHORT PEPTIDES DERIVED FROM THE TERMINAL SEGMENTS OF THE PROTEASE

被引:13
|
作者
SCHRAMM, HJ
BREIPOHL, G
HANSEN, J
HENKE, S
JAEGER, E
MEICHSNER, C
RIESS, G
RUPPERT, D
RUCKNAGEL, KP
SCHAFER, W
SCHRAMM, W
机构
[1] HOECHST AG,W-6230 FRANKFURT 80,GERMANY
[2] BAYER AG,W-5600 WUPPERTAL,GERMANY
[3] UNIV MUNICH,HAMOSTASEOL ABT,W-8000 MUNICH 2,GERMANY
关键词
D O I
10.1016/0006-291X(92)90687-G
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The active HIV-1 protease is a homodimeric enzyme. A β-sheet consisting of N- and C-terminal segments provides the main driving force for dimerization of the inactive protomers. Several short peptides with sequences derived from the N- and C-termini of the protease were tested for inhibition of protease activity and for inhibition of HIV-1 replication in lymphocytes. Medium inhibitory activity was found with each of the peptides in the enzyme test and no inhibition of the lymphocytes was found up to 200 μg/ml. The enzyme tests indicate that HIV-1 protease is the target of the inhibitory action. Synergistic action could not be found with pairs of the peptides derived from the two different termini. Prolonged incubation with one of the peptides increased inhibition indicating a slow dissociation of the protease dimers. No cytotoxic effect of the inhibitors could be found below 200 μg/ml. © 1992.
引用
收藏
页码:980 / 985
页数:6
相关论文
共 50 条
  • [21] Structural Basis for HTLV-1 Protease Inhibition by the HIV-1 Protease Inhibitor Indinavir
    Kuhnert, Maren
    Steuber, Holger
    Diederich, Wibke E.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (14) : 6266 - 6272
  • [22] Interface targeting peptides as inhibitors of HIV-1 protease mutants
    Schramm, Hans J.
    Schramm, Wolfgang
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 51 - 51
  • [23] Targeting the dimerization interface of HIV-1 protease: Inhibition with cross-linked interfacial peptides
    Zutshi, R
    Franciskovich, J
    Shultz, M
    Schweitzer, B
    Bishop, P
    Wilson, M
    Chmielewski, J
    [J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (21) : 4841 - 4845
  • [24] HIV-1 protease inhibitor
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [25] HIV-1 Protease Cleavages
    Abdullah, Muhammad
    Khawaja, Seher Ansar
    Farooq, Muhammad
    [J]. 4TH INTERNATIONAL CONFERENCE ON INNOVATIVE COMPUTING (IC)2, 2021, : 873 - +
  • [26] INHIBITORS OF HIV-1 PROTEASE
    MEEK, TD
    [J]. JOURNAL OF ENZYME INHIBITION, 1992, 6 (01): : 65 - 98
  • [27] HIV-1 protease inhibitors
    Eron, JJ
    [J]. CLINICAL INFECTIOUS DISEASES, 2000, 30 : S160 - S170
  • [28] INHIBITORS OF HIV-1 PROTEASE
    DREYER, GB
    CARR, T
    LAMBERT, DM
    TOMASZEK, T
    MEEK, T
    CACCIAVILLANI, E
    PETTEWAY, SR
    MOORE, M
    DEBOUCK, C
    METCALF, BW
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1990, 200 : 83 - MEDI
  • [29] HIV-1 protease inhibitors
    不详
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (08) : 438 - 439
  • [30] Designing promiscuous inhibitors: Lessons learned from HIV-1 protease inhibition
    Shen, Yang
    Radhakrishnan, Mala L.
    Tidor, Bruce
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241